- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 119.82M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $9.77K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$3.67M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$3.42M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.78M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.72M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.81M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.83M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $685.16K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $682.75K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.17M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.53M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 11.98M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $18.92K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$330.6K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$377.3K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$409.42K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.66K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $827 |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.49K |